BC Week In Review | Nov 25, 2013
Company News

Aphios neurology, ophthalmic news

Aphios said it will spin off a wholly owned subsidiary, Amylon LLC, to develop and commercialize APH-1104 to treat mild to moderate Alzheimer's disease (AD) and other disorders, such as Down's syndrome, Parkinson's disease (PD)...
Items per page:
1 - 1 of 1